Showing results (201-210 of 250) with videos related to
Sort By:
Pageof 25
Diabetes Research and Clinical Practice|June 16, 2005
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndromeGiuseppe Derosa, Arrigo F G Cicero, Antonio Gaddi, et al.Current Medical Research and Opinion|June 27, 2009
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patientsGiuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 16, 2010
Candesartan effect on inflammation in hypertensionGiuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, et al.Diabetes Technology & Therapeutics|February 23, 2013
A randomized, double-blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetes patients already treated with pioglitazone and metformin: a 3-year studyGiuseppe Derosa, Arrigo F G Cicero, Ivano G Franzetti, et al.Journal of Cellular Physiology|July 12, 2017
Evaluation of BAG3 levels in healthy subjects, hypertensive patients, and hypertensive diabetic patientsGiuseppe Derosa, Pamela Maffioli, Alessandra Rosati, et al.Obesity Research|September 2, 2004
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian womenGiuseppe Derosa, Roberto Fogari, Mario Nello Piccinni, et al.European Journal of Pharmacology|June 8, 2011
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patientsGiuseppe Derosa, Pietro Putignano, Antonio C Bossi, et al.Diabetes Technology & Therapeutics|March 10, 2009
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot studyGiuseppe Derosa, Sibilla A T Salvadeo, Roberto Mereu, et al.Minerva Gastroenterology|October 5, 2020
Quercetin Phytosome® as a potential candidate for managing COVID-19Francesco DI Pierro, Amjad Khan, Alexander Bertuccioli, et al.Journal of Clinical Pharmacy and Therapeutics|August 5, 2009
Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatmentGiuseppe Derosa, A D'Angelo, I G Franzetti, et al.Pageof 25